Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-18-000006

Director acquired 161,374 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pfeifer Eugene M Director 2018-02-26 Grant or award +161,374 $0.12 $19,994 233,414 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…